FLCCC | Front Line COVID-19 Critical Care Alliance
FLCCC | Front Line COVID-19 Critical Care Alliance

Latest Updates

Ivermectin Reduces COVID-19 Mortality by 92%

The Latest Peer-Reviewed Research: Ivermectin Reduces Mortality Rate from COVID-19 by 92% With Regular Use A strictly controlled study of over 88,000 people showed a direct relationship between the dose of ivermectin and the level of protection against the SARS-CoV-2 virus WASHINGTON, D.C. – An international team of physicians and scientists recently completed the second phase of one of the largest controlled studies on the efficacy of ivermectin to prevent outcomes related to COVID-19 infection. [...]

September 2, 2022|Latest Updates|

Documentary Seeks “Truth” on Ivermectin

 New from filmmaker Mikki Willis, Ivermectin:  The Truth examines all that is true and untrue about the repurposed drug included in FLCCC protocols. The video is to “correct the narrative and to reveal the motive behind the smear campaign against one of the safest and most effective medicines of this era."

August 31, 2022|Latest Updates|

FLCCC Statement on Resignation of Anthony Fauci, MD

The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, is pleased to learn that Anthony Fauci will be leaving government service at the end of the year. Unfortunately,the damage he has done to medical research, science and public health over his long career will be felt for years to come. Dr. Fauci’s career is a clear demonstration of what many fear most from our government: [...]

August 23, 2022|Latest Updates|

FLCCC Mourns Dr. Vladimir Zelenko, Early COVID treatment Advocate

FLCCC mourns the loss of Dr. Vladimir Zelenko, fierce advocate for early COVID treatment The entire team at FLCCC is saddened to hear of the loss of a great friend and fellow supporter of early treatment for COVID-19. We extend our deepest condolences and sympathies to the Zelenko family and pray they find the strength to see them through this difficult time. “Dr. Zelenko stepped up and fought for access to early treatment when few [...]

June 30, 2022|Latest Updates|

FLCCC Responds to ACTIV-6 Trial

The authors of the recent preprint, ‘Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial’, reported they did not find a “clinically relevant effect” for treatment of early COVID-19 with ivermectin. In public statements, the study's authors and the mass media have positioned the trial (known as ACTIV-6) as demonstrating a negative outcome for ivermectin, whereas the trial proved the opposite. ACTIV-6 severely limited the use of [...]

June 14, 2022|Latest Updates|

FLCCC Recognizes New Legislation in N. H. to Allow Ivermectin OTC

The FLCCC is pleased with the recent legislative developments in New Hampshire that will allow over the counter (OTC) access to ivermectin, an FDA approved drug that currently requires a prescription to be dispensed. If the legislation, House Bill 1022, is signed into law by the Governor of New Hampshire, residents aged 18 and over will have access to ivermectin through a pharmacy without a prescription. FLCCC co-founder and world-renowned intensive care specialist, Paul Marik, [...]

May 10, 2022|Latest Updates|

FLCCC Responds to WSJ Article on TOGETHER Trial

On March 18, 2022, The Wall Street Journal published an article entitled: ‘Ivermectin Didn’t Reduce Covid-19 Hospitalizations in Largest Trial to Date’. The results of this trial, which was predetermined to show ivermectin as ineffective, affirms the need for early treatment against COVID-19 and confirms that conflicted groups continue to influence competitor trials, ensuring they are designed to fail. Several organizations associated with the trial have a paid client relationship with Pfizer, which has secured [...]

March 18, 2022|Latest Updates|

Virginia Recognizes Dr. Marik for Distinguished Career

On March 11, the Virginia House of Delegates passed a resolution by unanimous vote that commends Paul Marik, MD, one of the world’s leading critical care physicians, for his distinguished career and courageous life-saving work during the COVID-19 pandemic. HR 228 recognizes Dr. Marik for “his courageous treatment of critically ill COVID-19 patients and his philanthropic efforts to share his effective treatment protocols with physicians around the world.” Virginia legislators occasionally honor members of the [...]

March 18, 2022|Latest Updates|
Go to Top